14.6 C
New York
Saturday, November 21, 2026
- Advertisement -spot_img

TAG

Gaucher disease

Venglustat Wins FDA Approval for Rare Brain Disorder

The FDA approved Sanofi's venglustat, sold as Infilbray, the first drug for the brain and nerve symptoms of type 3 Gaucher disease in adults and children.

Latest news

- Advertisement -spot_img